CSF3 and neutropenia: Administration of granulocyte colony-stimulating factor (G-CSF) for the treatment of chemotherapy-induced neutropenia may increase physiological 18F-FDG uptake in the bone marrow; therefore, an interval of at least 10 days is recommended after G-CSF administration to minimize the effect of G-CSF on the bone marrow [39].